Khartis Therapeutics
PrivateLast Round
Series B
Aug 13, 2026
Total Funding Raised
$95M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Khartis Therapeutics is a biotechnology company that develops oral small-molecule medicines for immunological and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Khartis Therapeutics Comparables
Compare Khartis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sling Therapeutics | 86% | |
| Ethyreal Bio | 81% | |
| Yarrow Bioscience, Inc. | 81% |
Khartis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2026 |
Khartis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forge Life Science Partners | Series B |
| Foresite Capital | Series B, Series A |
| Alexandria Venture Investments | Series B |
| Lilly Asia Ventures | Series B, Series A |
| Nextech Invest | Series B, Series A |
| Longwood Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2026
$50M round led by Forge Life Science Partners.
Recent news
Latest coverage and updates
- receives_financingAug 13, 2026
Khartis THERAPEUTICS, INC. received financing of $50M in Series B on Aug 13th '26.
Khartis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Khartis Therapeutics's valuation, stock price, and market status.
Is Khartis Therapeutics a public or private company?
Khartis Therapeutics is a private company.
What is the current stock price of Khartis Therapeutics?
Khartis Therapeutics is a private company with no public stock price. Caplight tracks Khartis Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Khartis Therapeutics worth (valuation)?
Valuation information for Khartis Therapeutics is not publicly available.
Can I buy Khartis Therapeutics stock?
Khartis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Khartis Therapeutics's last funding round?
Khartis Therapeutics's most recent funding round was Series B on August 13, 2026.
Who are the main investors in Khartis Therapeutics?
Key investors in Khartis Therapeutics include Forge Life Science Partners.
Will Khartis Therapeutics IPO soon?
No public IPO plans have been announced for Khartis Therapeutics.
How can I track Khartis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Khartis Therapeutics's secondary market activity and sign up for updates.